|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 38/48 | |||
| A61K 8/99 | |||
| A61P 17/00 | |||
| A61K 38/16 |
| (11) | Number of the document | 1796646 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05791297.4 |
| Date of filing the European patent application | 2005-08-24 | |
| (97) | Date of publication of the European application | 2007-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2009-02-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/030281 |
| Date | 2005-08-24 |
| (87) | Number | WO 2006/039014 |
| Date | 2006-04-13 |
| (30) | Number | Date | Country code |
| 957004 | 2004-10-01 | US |
| (72) |
FIRST, Eric, R., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine CA 92612,
US
|
| (54) | COSMETIC NEUROTOXIN COMPOSITIONS COMPRISING A BOTULINUM TOXIN COMPONENT AND METHODS |
| COSMETIC NEUROTOXIN COMPOSITIONS COMPRISING A BOTULINUM TOXIN COMPONENT AND METHODS |